Danaher designs, manufactures and markets medical, industrial and commercial products and services. Co.'s segments are: Life Sciences, which provides instruments to study genes, proteins, metabolites and cells, in order to understand the causes of disease, identify therapies, and test drugs and vaccines; Diagnostics, which provides analytical instruments, reagents, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions; and Environmental and Applied Solutions, which provides products and services to protect resources and global food and water supplies. The DHR stock yearly return is shown above.
The yearly return on the DHR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2013 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the DHR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|